Safety evaluation of cellular-type artificial blood based on pharmacokinetic analysis and its use in medical gas delivery

Medicine & Life Sciences

• Blood Substitutes 89%
• Gases 53%
• Hemoglobins 50%
• Pharmacokinetics 47%
• Safety 36%
• Carbon Monoxide 18%
• Animal Models 6%
• Animal Disease Models 5%
• Hemorrhagic Shock 5%
• Membrane Lipids 5%
• Isotopes 4%
• Hyperlipidemias 4%
• Liposomes 4%
• Phospholipids 4%
• Erythrocytes 3%
• Fibrosis 3%
• Pharmacology 3%
• Membranes 2%
• Animals 2%
• Therapeutics 1%

Chemical Compounds

• Artificial Blood 100%
• Hemoglobin 58%
• Safety 54%
• Pharmacokinetics 47%
• Gas 33%
• Carbon Monoxide 8%
• Pharmacological Effect 6%
• Bilayer Membrane 5%
• Carbon Atom 4%
• Liposome 4%
• Disorder 4%
• Phospholipid 4%
• Red 3%